A customer from outside of the u.S.Reported observation of depressed atellica im alpha fetoprotein (afp) results which were discordant relative to repeat testing.The ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens is investigating.
|
Mdr 1219913-2022-00306 was initially filed on 2022-09-15.Additional information, 2022-11-09: siemens has concluded the investigation.A customer from outside the united states reported observation of depressed atellica im alpha fetoprotein (afp) results which were discordant relative to repeat testing.Imprecision was observed for several samples when repeat testing was performed using different instruments.A low bias was seen for results produced by one instrument/reagent-pack combination, but quality control results were within range, and calibration did not demonstrate any bias.The affected samples were no longer available for additional testing.It is noted that the observed imprecision affected low-end afp results for a limited number of samples.Siemens cannot rule out sample-specific issues as a cause of the imprecision.A product performance issue has not been identified.The customer is operational, and has reported no additional discrepancies.No further investigation is required.Note: in section h6, the codes for investigation findings and investigation conclusion have been updated.
|